Tech Company Cyber Insurance Premium

Created on 14 May 2016
Source Code Control Limited user picture

Source Code Control Limited

SMEs

Creator



Looking for Partnership

Looking for Lead Partner


Any tech company developing software as part of their tech solution( Firmware in IoT, applications, portals) could have risk developed in. Most cyber strategies are to defend and react to attacks.

Most companies do not look at the risk in open source software components developers are using to build an application.

In a Cyber Compliance/assurance there should be a layer for looking at code if it is relevant to the organisation looking for insurance. We can produce a report with all the components of the applications how they are licensed (which can be another risk you may want to look at) and whether there are known security vulnerabilities.

Panama Papers - ; Mossack Fonseca were riddled with security flaws. For instance, Wired UK noted that the firm’s client portal was vulnerable to the DROWN attack, a security exploit targeting servers supporting the obsolete and insecure SSL v2 protocol.

or 

Open SSL ;

Any company that has processes in place to have visibility of vulnerabilities as they happen and can fix them in a defined SLA are a better insurance bet. If your client supplies software as part of their solution to customers, they would be open to legal action if they are compromised


 Innovation
 IT Applications
 Open Source

Recommended Calls for This Idea
If you know a call that can work with this idea

recommend a call  

Looking for Similar Ideas?
Here are suggestions of similar ideas

PSD-95 inhibition in neurogenerative disorders

Created on 14 Jul 2017
...
 Innovation
 
...

Avilex Pharma has developed an exceptionally high-affinity inhibitor of the intracellular scaffolding protein, postsynaptic density protein 95 (PSD-95), which bridges the NMDA glutamate receptor and neuronal nitric oxide synthase (nNOS). Avilex Ph ...

Interested in Tool Compounds to Explore Neurodegenrative Conditions (Avilex Pharma)

Created on 14 Jul 2017
...
 Innovation
 
...

Avilex Pharma is specialized in designing and developing peptide based inhibitors targeting PDZ domain proteins, in particular PSD-95, which is a post-synaptic density protein involved in neurodegenerative disorders. Avilex Pharma offers the provi ...

Interested in a Partnership (Interquimica (Instituto Tecnologias Quimicas Emer...)

Created on 07 Jun 2017
...
 Innovation
 
...

Partners interesed in participating in the future call of H2020 focused in material development and use of nanoparticles.